Medication-Assisted Treatment in Pregnancy
This brief outlines some of the barriers that pregnant and postpartum women with opioid use disorder face, as well as examples of state legislation passed to address recovery program implementation, ...
This brief outlines some of the barriers that pregnant and postpartum women with opioid use disorder face, as well as examples of state legislation passed to address recovery program implementation, ...
This report highlights six public health approaches for addressing the rising incidence of substance use disorder and neonatal abstinence syndrome and draws out the critical role that state health ...
Learn about how Louisiana’s perinatal quality collaborative is caring for pregnant and postpartum people with substance use disorder by reducing stigma and radical collaboration.
With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To ...
In February 2019, ASTHO surveyed its members to understand how data is being utilized to address these harms in their jurisdictions. This brief summarizes the results of this survey and highlights ...
Opioid and substance use disorders (SUD) continue to affect families beyond pregnancy; in 2017, about one in eight U.S. children lived in a household where at least one parent had a SUD in the prior ...
Substance use disorder (SUD) among pregnant and postpartum women is an increasingly pressing public health concern.
ASTHO Member and West Virginia Health Commissioner Rahul Gupta Testifies on Nation’s Opioid Epidemic ARLINGTON, VA—Rahul Gupta, commissioner and state health officer at the West Virginia Department ...
ASTHO interview with Elizabeth Harvey, PhD, MPH, a CDC Senior Maternal and Child Health Epidemiology Program assignee to the Tennessee Department of Health. Harvey shares her thoughts on the progress ...
This report focuses on promising strategies in four different policy areas to address rising congenital syphilis rates. While no single policy solution will address the structural challenges to ...
In 2020, the COVID-19 pandemic exacerbated barriers to care and treatment for individuals experiencing opioid use disorder. Experts estimate a record-setting 90,000 people died of a drug overdose in ...
The second half of Public Health Review's story on the opioid epidemic explores how coalitions in Kentucky are driving prevention efforts, what public health practitioners in West Virginia are ...
In the Public Health Review podcast debut, host Robert Johnson speaks with public health officials from Alaska, Kentucky, and West Virginia about the ongoing opioid epidemic in the U.S. and its ...
This brief outlines key considerations for state health departments to address the increase in overdose-related deaths during the postpartum period.
Hazel Dean discusses the serious threat to women's health presented by the convergence of syphilis and drug use.
Perinatal substance use is a serious public health issue, resulting in detrimental and even life-threatening fetal outcomes, and it continues to grow.
Neonatal Abstinence Syndrome (NAS) has become more prevalent in the United States, with the hospitalization rate increasing from 2.9 to 7.3 hospitalizations per 1,000 newborn births between 2009 and ...
This four-part infographic series illustrates key strategies for addressing common challenges and barriers related to increasing access to contraception.
Health Officials Respond to Alarming Increases in Congenital Syphilis ARLINGTON, VA—Newborn syphilis cases have more than doubled in the last 4 years, and last year, the United States saw the most ...
In 2023 legislative sessions, states considered measures to improve access to care for pregnant people experiencing substance use disorder, increase provider knowledge of screening and treatment ...